One of the most compelling things about artificial intelligence chat technologies like ChatGPT and AIChat is their ability to generate human-like responses - but that may
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh